Factors Associated With Favorable Response in Real-World Use of Botulinum Toxin Type A Products for Adult Patients With Upper Limb Spasticity

MLA

Jorge Jacinto, et al. “Factors Associated With Favorable Response in Real-World Use of Botulinum Toxin Type A Products for Adult Patients With Upper Limb Spasticity.” Toxicon, vol. 214, July 2022, pp. S26–27. EBSCOhost, https://doi.org/10.1016/j.toxicon.2021.11.065.

APA

Jorge Jacinto, Stephen Ashford, Klemens Fheodoroff, Natalya Danchenko, Françoise Calvi-Gries, Yann Bourhis, John Whalen, & Lynne Turner-Stokes. (2022). Factors Associated With Favorable Response in Real-World Use of Botulinum Toxin Type A Products for Adult Patients With Upper Limb Spasticity. Toxicon, 214, S26–S27. https://doi.org/10.1016/j.toxicon.2021.11.065

Chicago

Jorge Jacinto, Stephen Ashford, Klemens Fheodoroff, Natalya Danchenko, Françoise Calvi-Gries, Yann Bourhis, John Whalen, and Lynne Turner-Stokes. 2022. “Factors Associated With Favorable Response in Real-World Use of Botulinum Toxin Type A Products for Adult Patients With Upper Limb Spasticity.” Toxicon 214 (July): S26–27. doi:10.1016/j.toxicon.2021.11.065.